Poland
· Delayed Price · Currency is PLN Mercator Medical Statistics
Total Valuation
Mercator Medical has a market cap or net worth of PLN 556.91 million. The enterprise value is 334.94 million.
| Market Cap | 556.91M |
| Enterprise Value | 334.94M |
Important Dates
The last earnings date was Thursday, September 12, 2024.
| Earnings Date | Sep 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Mercator Medical has 9.77 million shares outstanding. The number of shares has increased by 13.95% in one year.
| Shares Outstanding | 9.77M |
| Shares Change (YoY) | +13.95% |
| Shares Change (QoQ) | +17.27% |
| Owned by Insiders (%) | 4.11% |
| Owned by Institutions (%) | 1.35% |
| Float | 3.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.23 |
| PB Ratio | 0.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -138.23 |
| EV / Sales | 0.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.95 |
Financial Position
The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.60.
| Current Ratio | 7.01 |
| Quick Ratio | 3.92 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -100.67 |
Financial Efficiency
Return on equity (ROE) is -0.52% and return on invested capital (ROIC) is -2.50%.
| Return on Equity (ROE) | -0.52% |
| Return on Assets (ROA) | -2.22% |
| Return on Capital (ROIC) | -2.50% |
| Revenue Per Employee | 494,930 |
| Profits Per Employee | -2,521 |
| Employee Count | 961 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 3.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.63% in the last 52 weeks. The beta is 2.71, so Mercator Medical's price volatility has been higher than the market average.
| Beta (5Y) | 2.71 |
| 52-Week Price Change | +36.63% |
| 50-Day Moving Average | 50.90 |
| 200-Day Moving Average | 45.79 |
| Relative Strength Index (RSI) | 53.58 |
| Average Volume (20 Days) | 25,260 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Mercator Medical had revenue of PLN 475.63 million and -2.42 million in losses. Loss per share was -0.24.
| Revenue | 475.63M |
| Gross Profit | 104.66M |
| Operating Income | -34.93M |
| Pretax Income | 8.10M |
| Net Income | -2.42M |
| EBITDA | -14.82M |
| EBIT | -34.93M |
| Loss Per Share | -0.24 |
Balance Sheet
The company has 224.29 million in cash and 5.11 million in debt, giving a net cash position of 219.18 million or 22.43 per share.
| Cash & Cash Equivalents | 224.29M |
| Total Debt | 5.11M |
| Net Cash | 219.18M |
| Net Cash Per Share | 22.43 |
| Equity (Book Value) | 845.53M |
| Book Value Per Share | 80.95 |
| Working Capital | 506.02M |
Cash Flow
In the last 12 months, operating cash flow was 3.33 million and capital expenditures -23.09 million, giving a free cash flow of -19.76 million.
| Operating Cash Flow | 3.33M |
| Capital Expenditures | -23.09M |
| Free Cash Flow | -19.76M |
| FCF Per Share | -2.02 |
Margins
Gross margin is 22.00%, with operating and profit margins of -7.34% and -0.51%.
| Gross Margin | 22.00% |
| Operating Margin | -7.34% |
| Pretax Margin | 1.70% |
| Profit Margin | -0.51% |
| EBITDA Margin | -3.12% |
| EBIT Margin | -7.34% |
| FCF Margin | -4.16% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 4.39%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 4.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -13.95% |
| Shareholder Yield | -9.56% |
| Earnings Yield | -0.41% |
| FCF Yield | -3.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |